Early detection of lung cancer using a spectroscopic liquid biopsy

• Research type

  Research Study

• Full title

  Early detection of lung cancer using a spectroscopic liquid biopsy.

• IRAS ID

  349449

• Contact name

  David Palmer

• Contact email

  david.palmer@dxcover.com

• Sponsor organisation

  Dxcover Ltd

• Clinicaltrials.gov Identifier

  n/a, n/a

• Duration of Study in the UK

  0 years, 11 months, 31 days

• Research summary

  Serum and/or plasma from blood samples from approximately 6500 patients taken from the iDx Lung cohort will be sent to Dxcover Ltd in Glasgow, Scotland, who will analyse them by Fourier-Transform Infra-red Spectroscopy in order to develop a machine learning model for the early detection of lung cancer. The samples and data will be fully anonymised with identifiable patient data removed. Spectroscopy is a low-resolution technique that does not reveal genome sequence or any other characteristics of the samples that could be used to identify patients.

• REC name

  London - Queen Square Research Ethics Committee

• REC reference

  25/PR/1481

• Date of REC Opinion

  21 Jan 2026

• REC opinion

  Further Information Favourable Opinion